Quick Answer
Dermata Therapeutics, Inc. reported Shares Outstanding of 2.66 million shares for fiscal year 2025.
Dermata Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 2.66M | +956.8% |
| 2024 | 251,725 | -3.9% |
| 2023 | 261,998 | -66.0% |
| 2022 | 770,115 | -90.8% |
| 2021 | 8.33M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 844,457 | -49.7% | +32.4% |
| June 30, 2025 | 637,757 | -8.0% | -89.4% |
| March 31, 2025 | 6.03M | -9.4% | +2296.5% |
| December 31, 2024 | 251,725 | -3.9% | -85.0% |
| September 30, 2024 | 1.68M | -47.4% | +142.0% |
| June 30, 2024 | 693,175 | -78.3% | -89.6% |
| March 31, 2024 | 6.66M | +178.9% | +2442.3% |
| December 31, 2023 | 261,998 | -66.0% | -91.8% |
- Dermata Therapeutics, Inc. showed an increase of +956.8% in Shares Outstanding compared to the prior fiscal year.
- Over the 2021–2025 period, Dermata Therapeutics, Inc.’s shares outstanding has declined by 68.1% (from 8.33 million shares to 2.66 million shares).
- The most recent figure is from Dermata Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: